Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chondroitin Sulfates | 6 | 2012 | 23 | 1.670 |
Why?
|
| Superoxide Dismutase-1 | 7 | 2022 | 45 | 1.450 |
Why?
|
| Oligosaccharides | 4 | 2012 | 33 | 0.950 |
Why?
|
| Aging | 6 | 2021 | 954 | 0.930 |
Why?
|
| Inflammation | 9 | 2024 | 598 | 0.860 |
Why?
|
| Animals | 35 | 2024 | 9954 | 0.790 |
Why?
|
| Mice | 25 | 2024 | 4402 | 0.770 |
Why?
|
| Cartilage | 5 | 2012 | 33 | 0.760 |
Why?
|
| Insulin Resistance | 5 | 2024 | 165 | 0.740 |
Why?
|
| Mitochondria | 7 | 2022 | 325 | 0.740 |
Why?
|
| Antibodies, Monoclonal | 3 | 2007 | 316 | 0.740 |
Why?
|
| Epitopes | 4 | 2012 | 171 | 0.690 |
Why?
|
| Proteoglycans | 4 | 2010 | 37 | 0.620 |
Why?
|
| Obesity | 4 | 2024 | 647 | 0.620 |
Why?
|
| Aging, Premature | 1 | 2018 | 3 | 0.600 |
Why?
|
| Caloric Restriction | 2 | 2018 | 73 | 0.570 |
Why?
|
| Endopeptidase Clp | 2 | 2018 | 9 | 0.560 |
Why?
|
| Neurons | 2 | 2024 | 273 | 0.540 |
Why?
|
| Adiponectin | 3 | 2011 | 29 | 0.510 |
Why?
|
| Mitochondrial Proteins | 4 | 2018 | 70 | 0.470 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2011 | 160 | 0.460 |
Why?
|
| Lactates | 1 | 2024 | 18 | 0.450 |
Why?
|
| Mice, Knockout | 11 | 2022 | 781 | 0.430 |
Why?
|
| Chondroitinases and Chondroitin Lyases | 1 | 2012 | 1 | 0.420 |
Why?
|
| Animal Fins | 1 | 2012 | 2 | 0.420 |
Why?
|
| Brain | 5 | 2021 | 697 | 0.410 |
Why?
|
| Adipose Tissue, White | 3 | 2018 | 16 | 0.380 |
Why?
|
| Carrier Proteins | 3 | 2009 | 245 | 0.380 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 2 | 2024 | 61 | 0.380 |
Why?
|
| Mitochondria, Muscle | 2 | 2015 | 39 | 0.370 |
Why?
|
| Membrane Proteins | 4 | 2018 | 466 | 0.370 |
Why?
|
| Electron Transport Complex IV | 3 | 2017 | 40 | 0.360 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2022 | 130 | 0.350 |
Why?
|
| Motor Neurons | 2 | 2022 | 41 | 0.350 |
Why?
|
| Liver Neoplasms | 2 | 2022 | 164 | 0.340 |
Why?
|
| Antioxidants | 2 | 2002 | 222 | 0.330 |
Why?
|
| Liver | 3 | 2021 | 415 | 0.320 |
Why?
|
| Sharks | 4 | 2012 | 7 | 0.320 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 1394 | 0.310 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 21 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 1474 | 0.300 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2018 | 46 | 0.300 |
Why?
|
| Sarcopenia | 1 | 2018 | 41 | 0.300 |
Why?
|
| Necrosis | 1 | 2018 | 80 | 0.300 |
Why?
|
| Growth Substances | 2 | 2004 | 11 | 0.290 |
Why?
|
| Epididymis | 1 | 2017 | 5 | 0.290 |
Why?
|
| Fish Oils | 1 | 2017 | 9 | 0.280 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2004 | 29 | 0.280 |
Why?
|
| Polysaccharides | 1 | 2007 | 61 | 0.280 |
Why?
|
| Homeostasis | 1 | 2018 | 113 | 0.280 |
Why?
|
| Frailty | 1 | 2017 | 19 | 0.280 |
Why?
|
| Unfolded Protein Response | 5 | 2018 | 24 | 0.280 |
Why?
|
| Interleukin-10 | 1 | 2017 | 67 | 0.270 |
Why?
|
| Protein Binding | 5 | 2013 | 631 | 0.270 |
Why?
|
| Muscle, Skeletal | 3 | 2018 | 578 | 0.260 |
Why?
|
| Sensitivity and Specificity | 3 | 2018 | 509 | 0.260 |
Why?
|
| Myoblasts | 1 | 2015 | 5 | 0.260 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2007 | 54 | 0.260 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2007 | 128 | 0.250 |
Why?
|
| Cellular Senescence | 3 | 2022 | 121 | 0.250 |
Why?
|
| Biomarkers | 4 | 2022 | 731 | 0.240 |
Why?
|
| Plant Oils | 2 | 2002 | 9 | 0.240 |
Why?
|
| Protein Kinases | 3 | 2024 | 143 | 0.240 |
Why?
|
| Vitamin A | 2 | 2002 | 25 | 0.240 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2010 | 27 | 0.240 |
Why?
|
| beta Carotene | 2 | 2002 | 4 | 0.240 |
Why?
|
| Oxidative Stress | 4 | 2021 | 619 | 0.240 |
Why?
|
| Heparitin Sulfate | 1 | 2004 | 14 | 0.230 |
Why?
|
| Apoptosis | 1 | 2018 | 737 | 0.230 |
Why?
|
| Mammary Glands, Animal | 1 | 2004 | 33 | 0.230 |
Why?
|
| Fibrosis | 2 | 2021 | 115 | 0.230 |
Why?
|
| Adipose Tissue | 3 | 2024 | 179 | 0.220 |
Why?
|
| Models, Animal | 2 | 2018 | 128 | 0.210 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 143 | 0.210 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2011 | 31 | 0.210 |
Why?
|
| Dietary Supplements | 2 | 2002 | 212 | 0.210 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 21 | 0.210 |
Why?
|
| Fatty Liver | 2 | 2018 | 49 | 0.210 |
Why?
|
| Cell Proliferation | 1 | 2015 | 770 | 0.200 |
Why?
|
| Vitamin A Deficiency | 1 | 2002 | 9 | 0.200 |
Why?
|
| Heparin | 1 | 2002 | 110 | 0.200 |
Why?
|
| Drosophila melanogaster | 1 | 2002 | 61 | 0.200 |
Why?
|
| Caenorhabditis elegans | 1 | 2002 | 58 | 0.200 |
Why?
|
| Cytokines | 1 | 2004 | 437 | 0.190 |
Why?
|
| Cell Line | 3 | 2024 | 671 | 0.190 |
Why?
|
| Glycosaminoglycans | 1 | 2002 | 54 | 0.190 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 80 | 0.190 |
Why?
|
| Protein Phosphatase 2 | 1 | 2011 | 11 | 0.190 |
Why?
|
| Cytosol | 1 | 2011 | 47 | 0.190 |
Why?
|
| Neuronal Plasticity | 2 | 2010 | 49 | 0.190 |
Why?
|
| Protein Kinase C | 1 | 2011 | 72 | 0.190 |
Why?
|
| Xerophthalmia | 1 | 2001 | 1 | 0.190 |
Why?
|
| Diet, High-Fat | 3 | 2024 | 130 | 0.190 |
Why?
|
| Male | 9 | 2018 | 12866 | 0.190 |
Why?
|
| Uronic Acids | 2 | 2012 | 4 | 0.180 |
Why?
|
| Extracellular Space | 1 | 2010 | 25 | 0.180 |
Why?
|
| Interleukin-1beta | 2 | 2019 | 40 | 0.180 |
Why?
|
| Signal Transduction | 3 | 2017 | 1339 | 0.170 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2009 | 1 | 0.170 |
Why?
|
| Longevity | 2 | 2018 | 129 | 0.160 |
Why?
|
| Nerve Net | 1 | 2010 | 105 | 0.160 |
Why?
|
| Muscles | 1 | 2009 | 70 | 0.160 |
Why?
|
| Interleukin-6 | 2 | 2019 | 190 | 0.160 |
Why?
|
| Acceleration | 1 | 2018 | 16 | 0.150 |
Why?
|
| Geriatrics | 1 | 2018 | 41 | 0.150 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 239 | 0.150 |
Why?
|
| Gene Deletion | 1 | 2017 | 115 | 0.140 |
Why?
|
| Adiposity | 1 | 2017 | 87 | 0.130 |
Why?
|
| Receptor, Insulin | 2 | 2017 | 93 | 0.130 |
Why?
|
| Body Mass Index | 2 | 2018 | 384 | 0.130 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 268 | 0.130 |
Why?
|
| Glucose | 2 | 2024 | 190 | 0.130 |
Why?
|
| Carbohydrate Sequence | 2 | 2007 | 14 | 0.120 |
Why?
|
| Chromatography, Gel | 2 | 2007 | 36 | 0.120 |
Why?
|
| Disaccharides | 2 | 2006 | 21 | 0.120 |
Why?
|
| Hydrogen Peroxide | 3 | 2015 | 138 | 0.120 |
Why?
|
| Cell Death | 1 | 2024 | 110 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2013 | 9 | 0.110 |
Why?
|
| Down-Regulation | 2 | 2015 | 196 | 0.110 |
Why?
|
| Humans | 10 | 2024 | 26856 | 0.110 |
Why?
|
| Memory | 1 | 2013 | 71 | 0.110 |
Why?
|
| Flavonoids | 1 | 2013 | 31 | 0.110 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2013 | 31 | 0.110 |
Why?
|
| Arecaceae | 1 | 2002 | 1 | 0.100 |
Why?
|
| Peroxidases | 1 | 2002 | 6 | 0.100 |
Why?
|
| Acetylgalactosamine | 1 | 2012 | 2 | 0.100 |
Why?
|
| Purkinje Cells | 1 | 2012 | 7 | 0.100 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 1036 | 0.100 |
Why?
|
| Nerve Growth Factors | 1 | 2012 | 24 | 0.100 |
Why?
|
| Kinetics | 2 | 2004 | 538 | 0.100 |
Why?
|
| Sulfates | 1 | 2012 | 86 | 0.100 |
Why?
|
| Female | 5 | 2018 | 14462 | 0.100 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 220 | 0.090 |
Why?
|
| Hyaluronoglucosaminidase | 2 | 2007 | 3 | 0.090 |
Why?
|
| Rats | 3 | 2010 | 1536 | 0.090 |
Why?
|
| Oxygen Consumption | 3 | 2017 | 173 | 0.090 |
Why?
|
| Cholesterol | 2 | 2024 | 181 | 0.080 |
Why?
|
| Age Factors | 2 | 2018 | 716 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2018 | 81 | 0.080 |
Why?
|
| Carbohydrate Metabolism | 1 | 2018 | 28 | 0.070 |
Why?
|
| Models, Biological | 2 | 2011 | 446 | 0.070 |
Why?
|
| Static Electricity | 1 | 2007 | 34 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2018 | 129 | 0.070 |
Why?
|
| Molecular Conformation | 1 | 2007 | 66 | 0.070 |
Why?
|
| Carbohydrate Conformation | 1 | 2007 | 11 | 0.070 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2007 | 13 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 254 | 0.070 |
Why?
|
| Sheep | 1 | 2007 | 97 | 0.070 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 65 | 0.070 |
Why?
|
| Physical Endurance | 1 | 2017 | 86 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2018 | 176 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 118 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2018 | 300 | 0.070 |
Why?
|
| Brain Chemistry | 1 | 2006 | 22 | 0.070 |
Why?
|
| Biochemistry | 1 | 2006 | 10 | 0.070 |
Why?
|
| Cell Shape | 1 | 2015 | 15 | 0.060 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2015 | 21 | 0.060 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2015 | 12 | 0.060 |
Why?
|
| Body Composition | 1 | 2018 | 260 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2017 | 198 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 106 | 0.060 |
Why?
|
| Glycolysis | 1 | 2015 | 82 | 0.060 |
Why?
|
| Muscle Strength | 1 | 2017 | 214 | 0.060 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 2 | 2010 | 7 | 0.060 |
Why?
|
| Syndecans | 1 | 2004 | 2 | 0.060 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2017 | 62 | 0.060 |
Why?
|
| Syndecan-4 | 1 | 2004 | 4 | 0.060 |
Why?
|
| Syndecan-1 | 1 | 2004 | 12 | 0.060 |
Why?
|
| Time Factors | 2 | 2002 | 1564 | 0.060 |
Why?
|
| Spinal Cord | 1 | 2006 | 202 | 0.060 |
Why?
|
| Fructose | 1 | 2024 | 22 | 0.060 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2024 | 17 | 0.060 |
Why?
|
| Insulin | 2 | 2018 | 309 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 352 | 0.050 |
Why?
|
| Adenosine Triphosphate | 2 | 2014 | 115 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2010 | 537 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2015 | 395 | 0.050 |
Why?
|
| Paralysis | 1 | 2022 | 9 | 0.050 |
Why?
|
| Fibroblast Growth Factor 10 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Biotinylation | 1 | 2002 | 19 | 0.050 |
Why?
|
| Decapodiformes | 1 | 2002 | 11 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2002 | 21 | 0.050 |
Why?
|
| Dasatinib | 1 | 2022 | 16 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 14 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2004 | 239 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2022 | 68 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2002 | 5 | 0.050 |
Why?
|
| Genome | 1 | 2002 | 53 | 0.050 |
Why?
|
| Diterpenes | 1 | 2002 | 19 | 0.050 |
Why?
|
| Serine | 1 | 2011 | 47 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2011 | 44 | 0.050 |
Why?
|
| Palm Oil | 1 | 2001 | 1 | 0.050 |
Why?
|
| Metformin | 1 | 2011 | 32 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 408 | 0.050 |
Why?
|
| Protein Transport | 1 | 2011 | 152 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2011 | 262 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 588 | 0.050 |
Why?
|
| India | 1 | 2001 | 137 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2021 | 264 | 0.040 |
Why?
|
| Sensory Deprivation | 1 | 2010 | 5 | 0.040 |
Why?
|
| Visual Cortex | 1 | 2010 | 8 | 0.040 |
Why?
|
| Darkness | 1 | 2010 | 17 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2001 | 73 | 0.040 |
Why?
|
| Phenotype | 1 | 2022 | 664 | 0.040 |
Why?
|
| Axons | 1 | 2010 | 24 | 0.040 |
Why?
|
| Visual Perception | 1 | 2010 | 44 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2011 | 559 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2010 | 62 | 0.040 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2019 | 14 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2002 | 328 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2019 | 43 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 2009 | 19 | 0.040 |
Why?
|
| Aldehydes | 1 | 2019 | 55 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2019 | 134 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2001 | 701 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 110 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 69 | 0.040 |
Why?
|
| Receptors, Adiponectin | 1 | 2008 | 5 | 0.040 |
Why?
|
| Infant | 1 | 2002 | 963 | 0.040 |
Why?
|
| Calcium | 1 | 2009 | 231 | 0.040 |
Why?
|
| Hippocampus | 1 | 2019 | 186 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2001 | 1090 | 0.040 |
Why?
|
| Adipogenesis | 1 | 2017 | 17 | 0.040 |
Why?
|
| Molecular Chaperones | 1 | 2017 | 48 | 0.030 |
Why?
|
| p21-Activated Kinases | 1 | 2016 | 6 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 15 | 0.030 |
Why?
|
| Triglycerides | 1 | 2017 | 116 | 0.030 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 24 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2002 | 2267 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 147 | 0.030 |
Why?
|
| Kidney | 1 | 2016 | 274 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2014 | 61 | 0.030 |
Why?
|
| Mitochondria, Heart | 1 | 2014 | 23 | 0.030 |
Why?
|
| Superoxides | 1 | 2014 | 60 | 0.030 |
Why?
|
| Myocardium | 1 | 2014 | 171 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 624 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 118 | 0.030 |
Why?
|
| Blood Flow Velocity | 1 | 2013 | 63 | 0.030 |
Why?
|
| Maze Learning | 1 | 2013 | 78 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 60 | 0.030 |
Why?
|
| Heart | 1 | 2014 | 219 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 46 | 0.030 |
Why?
|
| Enzyme Stability | 1 | 2002 | 30 | 0.030 |
Why?
|
| Carbohydrates | 1 | 2002 | 15 | 0.030 |
Why?
|
| PPAR gamma | 1 | 2012 | 29 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2013 | 106 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2013 | 108 | 0.030 |
Why?
|
| Solubility | 1 | 2002 | 73 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 176 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2002 | 118 | 0.030 |
Why?
|
| Plant Leaves | 1 | 2002 | 56 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2013 | 155 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2013 | 93 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2002 | 113 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 261 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2002 | 84 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2002 | 453 | 0.020 |
Why?
|
| Melanoma | 1 | 2013 | 140 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 353 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 820 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 1259 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2013 | 802 | 0.020 |
Why?
|
| Neurocan | 1 | 2006 | 1 | 0.020 |
Why?
|
| Brevican | 1 | 2006 | 1 | 0.020 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2006 | 2 | 0.020 |
Why?
|
| Aggrecans | 1 | 2006 | 5 | 0.020 |
Why?
|
| Buffers | 1 | 2006 | 24 | 0.020 |
Why?
|
| Streptomyces | 1 | 2006 | 11 | 0.020 |
Why?
|
| Detergents | 1 | 2006 | 24 | 0.020 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 36 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 151 | 0.020 |
Why?
|